Edition:
United States

Profile: STAAR Surgical Co (STAA.OQ)

STAA.OQ on NASDAQ Stock Exchange Global Market

9.42USD
23 Sep 2016
Change (% chg)

$-0.08 (-0.84%)
Prev Close
$9.50
Open
$9.36
Day's High
$9.48
Day's Low
$9.27
Volume
28,183
Avg. Vol
42,359
52-wk High
$9.78
52-wk Low
$4.99

STAAR Surgical Company (STAAR), incorporated on April 3, 1986, designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. The Company's principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery. The Company makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. The Company operates under the brands STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX nanoPOINT, Epiphany and AquaFlow. Collamer is the brand name for STAAR's collagen copolymer lens material. STAAR sells its products in approximately 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

STAAR operates its manufacturing facility in Monrovia, California. The Monrovia manufacturing facility principally makes Collamer and silicone intraocular lenses (IOLs), and injector systems for its IOLs. It also manufactures the Visian implantable Collamer lenses (ICLs) and preloaded IOL injectors. STAAR manufactures the raw material for Collamer lenses (both IOLs and ICLs) and the AquaFlow Device (for the treatment of glaucoma) in a facility in Aliso Viejo, California. STAAR operates a distribution facility in Nidau, Switzerland under its wholly owned subsidiary, STAAR Surgical AG. The Nidau facility also maintains manufacturing capabilities for STAAR's ICL products and the AquaFlow Device. STAAR operates distribution facilities in Japan under its wholly owned subsidiary, STAAR Japan Inc. STAAR Japan's facility is located in Shin-Urayasu and its distribution facility is located in Ichikawa City. STAAR final packages its silicone preloaded IOL injectors at the Ichikawa City facility.

Visian ICL (ICLs)

The Company's refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). The field of refractive surgery includes both lens-based procedures, using products, such as ICL and laser-based procedures, such as LASIK. The ICL product line treats a range of refractive errors within commonly known vision disorders, such as myopia (nearsightedness), hyperopia (farsightedness) and astigmatism. The ICL folds for minimally invasive implantation behind the iris and in front of the natural crystalline lens, using techniques similar to those used to implant an IOL during cataract surgery, except that the natural lens remains intact in the eye. Lenses of this type are generically called phakic IOLs or phakic implants because they work along with the patient's natural lens, or phakos, rather than replacing it. The Company's ICL is available for myopia and hyperopia and is available in multiple models, powers and lengths totaling hundreds of different types of inventoried lenses.

Minimally Invasive Intraocular Lenses (IOLs)

The Company produces and markets a line of foldable IOLs for use in minimally invasive cataract surgical procedures. Because these lenses fold, surgeons can implant them into the eye through an incision of approximately three millimeter (mm) in length. STAAR offers both materials in approximately two differently configured styles: the single-piece design where both the optic and haptics are made of the same material and the three-piece design where Polyimide loop haptics are attached to the optic. STAAR also sells aspheric IOLs made of silicone and Collamer that use optical designs that produce a clearer image than traditional spherical lenses.

The Company develops and markets in the United States, the Toric IOL, which is a toric version of its single-piece silicone IOL, which is designed for cataract patients having pre-existing astigmatism. In Japan and Europe, it sells a Preloaded Injector with a silicone or acrylic IOL packaged and shipped in a pre-sterilized, disposable injector for use in cataract surgery. In China, it sells a Preloaded Injector with a silicone IOL packaged and shipped in a pre-sterilized disposable injector for use in cataract surgery.

The Company competes with Novartis, Abbott Medical Optics, Valeant and Ophtec.

Company Address

STAAR Surgical Co

1911 Walker Ave
MONROVIA   CA   91016
P: +1626.3037902
F: +1626.3032962

Company Web Links